Inventor
FILION MARIO
CA26 patents
⚠️ This page may combine multiple inventors who share the name “FILION MARIO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ALETHIA BIOTHERAPEUTICS INC
10 patentsUS7989160B2Aug 2, 2011
Polynucleotides and polypeptide sequences involved in the process of bone remodeling
ALETHIA BIOTHERAPEUTICS INC25 citations92
US9067984B2Jun 30, 2015
Methods of impairing osteoclast differentiation using antibodies that bind Siglec-15
ALETHIA BIOTHERAPEUTICS INC6 citations83
US9393302B2Jul 19, 2016
Antibodies against kidney associated antigen 1 and antigen binding fragments thereof
ALETHIA BIOTHERAPEUTICS INC5 citations82
US8900579B2Dec 2, 2014
Siglec-15 antibodies in treating bone loss-related disease
ALETHIA BIOTHERAPEUTICS INC8 citations82
US9493562B2Nov 15, 2016
Anti-Siglec-15 antibodies
ALETHIA BIOTHERAPEUTICS INC3 citations71
US9040246B2May 26, 2015
Methods of making antibodies that bind polypeptides involved in the process of bone remodeling
ALETHIA BIOTHERAPEUTICS INC1 citations62
US9388242B2Jul 12, 2016
Nucleic acids encoding anti-Siglec-15 antibodies
ALETHIA BIOTHERAPEUTICS INC2 citations60
US9512211B2Dec 6, 2016
Anti-clusterin antibodies and antigen binding fragments and their use to reduce tumor volume
ALETHIA BIOTHERAPEUTICS INC0 citations51
US7947436B2May 24, 2011
Polynucleotides and polypeptide sequences involved in the process of bone remodeling
ALETHIA BIOTHERAPEUTICS INC1 citations51
US9822170B2Nov 21, 2017
Co-use of a clusterin inhibitor with an EGFR inhibitor to treat cancer
ALETHIA BIOTHERAPEUTICS INC0 citations45
SOOKNANAN ROY RABINDRANAUTH
5 patentsUS8540988B2Sep 24, 2013
Antibodies that bind polypeptides involved in the process of bone remodeling
SOOKNANAN ROY RABINDRANAUTH13 citations91
US8431126B2Apr 30, 2013
Antibodies that bind polypeptides involved in the process of bone remodeling
SOOKNANAN ROY RABINDRANAUTH13 citations91
US8168181B2May 1, 2012
Methods of impairing osteoclast differentiation using antibodies that bind siglec-15
SOOKNANAN ROY RABINDRANAUTH15 citations91
US8216582B2Jul 10, 2012
Polynucleotides and polypeptide sequences involved in cancer
SOOKNANAN ROY RABINDRANAUTH9 citations83
US8444975B2May 21, 2013
Method for inhibiting bone resorption
SOOKNANAN ROY RABINDRANAUTH0 citations51
TREMBLAY GILLES BERNARD
5 patentsUS8580257B2Nov 12, 2013
Antibodies that specifically block the biological activity of kidney associated antigen 1 (KAAG1)
TREMBLAY GILLES BERNARD13 citations83
US8937163B2Jan 20, 2015
Antibodies against kidney associated antigen 1 and antigen binding fragments thereof
TREMBLAY GILLES BERNARD6 citations82
US8802826B2Aug 12, 2014
Anti-clusterin antibodies and antigen binding fragments and their use to reduce tumor volume
TREMBLAY GILLES BERNARD4 citations72
US8741289B2Jun 3, 2014
Siglec 15 antibodies in treating bone loss-related disease
TREMBLAY GILLES BERNARD3 citations71
US9855291B2Jan 2, 2018
Anti-kidney associated antigen 1 (KAAG1) antibodies
TREMBLAY GILLES BERNARD1 citations51
ADC THERAPEUTICS SA
3 patentsUS9828426B2Nov 28, 2017
Antibodies against kidney associated antigen 1 and antigen binding fragments thereof
ADC THERAPEUTICS SA3 citations71
US11084872B2Aug 10, 2021
Method for treating breast cancer
ADC THERAPEUTICS SA0 citations61
US10597450B2Mar 24, 2020
Antibodies against kidney associated antigen 1 and antigen binding fragments thereof
ADC THERAPEUTICS SA0 citations51
DAIICHI SANKYO CO LTD
3 patentsUS9695419B2Jul 4, 2017
Polynucleotides and polypeptide sequences involved in the process of bone remodeling
DAIICHI SANKYO CO LTD1 citations62
US9617337B2Apr 11, 2017
Siglec-15 antibodies in treating bone loss-related disease
DAIICHI SANKYO CO LTD1 citations61
USRE47672EOct 29, 2019
Methods of impairing osteoclast differentiation using antibodies that bind siglec-15
DAIICHI SANKYO CO LTD0 citations51